Home › Metastatic Cancer › Minnesota › Brooklyn Park
Metastatic Cancer clinical trials in Brooklyn Park, MN
3 studies for Metastatic Cancer are looking for participants at sites in and around Brooklyn Park (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- Mercy Hospital, Coon Rapids · 4 mi away
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RecruitingPhase 3
- Allina Health Cancer Institute - Mercy Hospital, Coon Rapids · 4 mi away
- Minnesota Oncology Hematology, P.A., Coon Rapids · 4 mi away
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
RecruitingPhase 1/2
- Minnesota Oncology Hematology, P.A., Coon Rapids · 4 mi away
Metastatic Cancer trials in other cities
- Houston, TX104 studies
- New York City, NY93 studies
- Nashville, TN70 studies
- Boston, MA63 studies
- Los Angeles, CA57 studies
- St. Louis, MO54 studies
- Arlington, VA53 studies
- Philadelphia, PA46 studies
- Chicago, IL45 studies
- San Antonio, TX44 studies
- Washington, DC43 studies
- Dallas, TX42 studies
Other studies in Brooklyn Park
- Non-Small Cell Lung Cancer10 studies
- Lung Cancer10 studies
- Colorectal Cancer7 studies
- Prostate Cancer6 studies
- Acute Myeloid Leukemia6 studies
- Breast Cancer6 studies
- Endometrial Cancer5 studies
- Melanoma5 studies
- Ovarian Cancer4 studies
- Colon Cancer4 studies
- Chronic Lymphocytic Leukemia4 studies
- Kidney Cancer (Renal Cell Carcinoma)4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.